☰

Viorica Ionut, Ph.D. - Publications

Affiliations: 
2005 University of Southern California, Los Angeles, CA, United States 
Area:
Endocrinology/Metabolism, Diabetes
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ionut V, Woolcott OO, Mkrtchyan HJ, Stefanovski D, Kabir M, Iyer MS, Liu H, Castro AV, Wu Q, Broussard JL, Kolka CM, Asare-Bediako I, Bergman RN. Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes. Plos One. 11: e0158703. PMID 27398720 DOI: 10.1371/Journal.Pone.0158703  0.622
2015 Kabir M, Iyer MS, Richey JM, Woolcott OO, Asare Bediako I, Wu Q, Kim SP, Stefanovski D, Kolka CM, Hsu IR, Catalano KJ, Chiu JD, Ionut V, Bergman RN. CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors. American Journal of Physiology. Endocrinology and Metabolism. 309: E747-58. PMID 26306598 DOI: 10.1152/Ajpendo.00196.2015  0.825
2015 Woolcott OO, Richey JM, Kabir M, Chow RH, Iyer MS, Kirkman EL, Stefanovski D, Lottati M, Kim SP, Harrison LN, Ionut V, Zheng D, Hsu IR, Catalano KJ, Chiu JD, et al. Corrections: High-Fat Diet-Induced Insulin Resistance does not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets. Plos One. 10: e0131033. PMID 26075612 DOI: 10.1371/journal.pone.0131033  0.813
2015 Woolcott OO, Richey JM, Kabir M, Chow RH, Iyer MS, Kirkman EL, Stefanovski D, Lottati M, Kim SP, Harrison LN, Ionut V, Zheng D, Hsu IR, Catalano KJ, Chiu JD, et al. High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets. Plos One. 10: e0123558. PMID 25855974 DOI: 10.1371/Journal.Pone.0123558  0.831
2015 Kolka CM, Richey JM, Castro AV, Broussard JL, Ionut V, Bergman RN. Lipid-induced insulin resistance does not impair insulin access to skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism. 308: E1001-9. PMID 25852002 DOI: 10.1152/Ajpendo.00015.2015  0.7
2015 Castro AV, Woolcott OO, Iyer MS, Kabir M, Ionut V, Stefanovski D, Kolka CM, Szczepaniak LS, Szczepaniak EW, Asare-Bediako I, Paszkiewicz RL, Broussard JL, Kim SP, Kirkman EL, Rios HC, et al. Increase in visceral fat per se does not induce insulin resistance in the canine model. Obesity (Silver Spring, Md.). 23: 105-11. PMID 25322680 DOI: 10.1002/Oby.20906  0.84
2014 Ionut V, Castro AV, Woolcott OO, Stefanovski D, Iyer MS, Broussard JL, Burch M, Elazary R, Kolka CM, Mkrtchyan H, Bediako IA, Bergman RN. Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia. American Journal of Physiology. Endocrinology and Metabolism. 307: E644-52. PMID 25117408 DOI: 10.1152/Ajpendo.00244.2014  0.739
2014 Ionut V, Castro AV, Woolcott OO, Stefanovski D, Iyer MS, Broussard JL, Mkrtchyan H, Burch M, Elazary R, Kirkman E, Bergman RN. Essentiality of portal vein receptors in hypoglycemic counterregulation: direct proof via denervation in male canines. Endocrinology. 155: 1247-54. PMID 24428530 DOI: 10.1210/En.2013-1794  0.736
2014 Ader M, Stefanovski D, Richey JM, Kim SP, Kolka CM, Ionut V, Kabir M, Bergman RN. Failure of homeostatic model assessment of insulin resistance to detect marked diet-induced insulin resistance in dogs. Diabetes. 63: 1914-9. PMID 24353184 DOI: 10.2337/Db13-1215  0.843
2014 Ader M, Stefanovski D, Kim SP, Richey JM, Ionut V, Catalano KJ, Hucking K, Ellmerer M, Van Citters G, Hsu IR, Chiu JD, Woolcott OO, Harrison LN, Zheng D, Lottati M, et al. Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity (Silver Spring, Md.). 22: 1238-45. PMID 24123967 DOI: 10.1002/Oby.20625  0.808
2014 Castro AVB, Nunes VdS, Ionut V, Bergman RN, Dib RE. Is visceral fat a better predictor of the incidence of impaired glucose tolerance or type 2 diabetes mellitus than subcutaneous abdominal fat: a systematic review and meta-analysis of cohort studies. Peerj. DOI: 10.7287/Peerj.Preprints.199V1  0.528
2013 Ionut V, Burch M, Youdim A, Bergman RN. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity (Silver Spring, Md.). 21: 1093-103. PMID 23512841 DOI: 10.1002/Oby.20364  0.493
2012 Stefanovski D, Youn JH, Rees M, Watanabe RM, Ader M, Ionut V, Jackson AU, Boehnke M, Collins FS, Bergman RN. Estimating hepatic glucokinase activity using a simple model of lactate kinetics. Diabetes Care. 35: 1015-20. PMID 22456868 DOI: 10.2337/Dc11-1540  0.674
2012 Kim SP, Woolcott OO, Hsu IR, Stefanoski D, Harrison LN, Zheng D, Lottati M, Kolka C, Catalano KJ, Chiu JD, Kabir M, Ionut V, Bergman RN, Richey JM. CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs. American Journal of Physiology. Endocrinology and Metabolism. 302: E1261-8. PMID 22374758 DOI: 10.1152/Ajpendo.00496.2011  0.835
2012 Woolcott OO, Bergman RN, Richey JM, Kirkman EL, Harrison LN, Ionut V, Lottati M, Zheng D, Hsu IR, Stefanovski D, Kabir M, Kim SP, Catalano KJ, Chiu JD, Chow RH. Simplified method to isolate highly pure canine pancreatic islets. Pancreas. 41: 31-8. PMID 21792087 DOI: 10.1097/Mpa.0B013E318221Fd0E  0.77
2011 Ionut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. Journal of Diabetes Science and Technology. 5: 1263-82. PMID 22027328 DOI: 10.1177/193229681100500536  0.501
2011 Kabir M, Stefanovski D, Hsu IR, Iyer M, Woolcott OO, Zheng D, Catalano KJ, Chiu JD, Kim SP, Harrison LN, Ionut V, Lottati M, Bergman RN, Richey JM. Large size cells in the visceral adipose depot predict insulin resistance in the canine model. Obesity (Silver Spring, Md.). 19: 2121-9. PMID 21836643 DOI: 10.1038/Oby.2011.254  0.817
2011 Stefanovski D, Richey JM, Woolcott O, Lottati M, Zheng D, Harrison LN, Ionut V, Kim SP, Hsu I, Bergman RN. Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA. Plos One. 6: e18134. PMID 21479217 DOI: 10.1371/Journal.Pone.0018134  0.859
2010 Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN. Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal. American Journal of Physiology. Endocrinology and Metabolism. 298: E346-53. PMID 19934401 DOI: 10.1152/Ajpendo.00280.2009  0.718
2010 Ionut V, Liu H, Mooradian V, Castro AV, Kabir M, Stefanovski D, Zheng D, Kirkman EL, Bergman RN. Novel canine models of obese prediabetes and mild type 2 diabetes. American Journal of Physiology. Endocrinology and Metabolism. 298: E38-48. PMID 19843874 DOI: 10.1152/Ajpendo.00466.2009  0.723
2009 Richey JM, Woolcott OO, Stefanovski D, Harrison LN, Zheng D, Lottati M, Hsu IR, Kim SP, Kabir M, Catalano KJ, Chiu JD, Ionut V, Kolka C, Mooradian V, Bergman RN. Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs. American Journal of Physiology. Endocrinology and Metabolism. 296: E1311-8. PMID 19366874 DOI: 10.1152/Ajpendo.90972.2008  0.759
2009 Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN. Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver. Diabetes. 58: 352-9. PMID 19011168 DOI: 10.2337/Db08-0875  0.743
2008 Ionut V, Zheng D, Stefanovski D, Bergman RN. Exenatide can reduce glucose independent of islet hormones or gastric emptying. American Journal of Physiology. Endocrinology and Metabolism. 295: E269-77. PMID 18492781 DOI: 10.1152/Ajpendo.90222.2008  0.72
2007 Hücking K, Hsu IR, Ionut V, Bergman RN. Deconvolution as a novel approach to analyze moment-to-moment free fatty acid release. Obesity (Silver Spring, Md.). 15: 2416-23. PMID 17925467 DOI: 10.1038/Oby.2007.287  0.749
2007 Harrison LN, Stefanovski D, Woolcott O, Lottati M, Zheng D, Ionut V, Kim SP, Hsu I, Kabir M, Catalano KJ, Chiu JD, Bergman RN, Richey JM. Cannabinoid receptor antagonist rimonabant prevents weight gain in dogs on a high fat diet The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A694-D  0.752
2006 Ionut V, Liberty IF, Hucking K, Lottati M, Stefanovski D, Zheng D, Bergman RN. Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action. American Journal of Physiology. Endocrinology and Metabolism. 291: E779-85. PMID 16720628 DOI: 10.1152/Ajpendo.00106.2005  0.855
2006 Ionut V, Stefanovski D, Lottati M, Kirkman E, Bergman RN. 148 PORTAL GLUCAGON-LIKE PROTEIN 1 PRODUCES AN INSULIN-INDEPENDENT REDUCTION IN GLYCEMIA BY INCREASING PERIPHERAL GLUCOSE DISPOSAL, WITHOUT CHANGING HEPATIC GLUCOSE BALANCE. Journal of Investigative Medicine. 54: S105.4-S105. DOI: 10.2310/6650.2005.X0004.147  0.837
2005 Ionut V, Hucking K, Liberty IF, Bergman RN. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia. 48: 967-75. PMID 15830188 DOI: 10.1007/S00125-005-1709-3  0.648
2005 Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, Kabir M, Bergman RN. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes. 54: 862-71. PMID 15734866 DOI: 10.2337/Diabetes.54.3.862  0.835
2005 Liberty IF, Ionut V, Kim SP, Ader M, Lottati M, Bergman RN. 165 HIV-PROTEASE INHIBITOR TREATMENT, A NEW CANINE EXPERIMENTAL MODEL OF INSULIN RESISTANCE: Journal of Investigative Medicine. 53: S106.5-S107. DOI: 10.2310/6650.2005.00005.164  0.876
2005 Ionut V, Liberty IF, Hucking K, Lottati M, Bergman RN. 162 DIRECT ACTION OF GLUCOSE AND GLUCAGON-LIKE PEPTIDE-1 ON THE PANCREAS MIGHT NOT BE RESPONSIBLE FOR A SIGNIFICANT PORTION OF THE INCRETIN RESPONSE DURING A MIXED MEAL Journal of Investigative Medicine. 53: S106.2-S106. DOI: 10.2310/6650.2005.00005.161  0.844
2004 Ionut V, Kirkman EL, Bergman RN. Investigation of the effect of acepromazine on intravenous glucose tolerance tests in dogs. American Journal of Veterinary Research. 65: 1124-7. PMID 15334847 DOI: 10.2460/Ajvr.2004.65.1124  0.653
2004 Ionut V, Hucking K, Bergman RN. 156 PORTAL GLUCAGON-LIKE PEPTIDE-1 AND PORTAL GLUCOSE SYNERGIZE TO STIMULATE INSULIN SECRETION. Journal of Investigative Medicine. 52: S106.3-S106. DOI: 10.1136/Jim-52-Suppl1-156  0.654
2003 Ader M, Kim S, Catalano K, Ionut V, Hucking K, Richey J, Kabir M, Bergman R. P.2.093 Marked increase in adiposity during olanzapine vs risperidone treatment: Results of a placebo-controlled study in normal dogs European Neuropsychopharmacology. 13: S320-S321. DOI: 10.1016/S0924-977X(03)92046-3  0.777
Show low-probability matches.